The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections
Open accessAbstract
Severe COVID-19 disease is associated with an increase in pro-inflammatory markers, such as IL-1, IL-6, and tumor necrosis alpha, less CD4 interferon-gamma expression, and fewer CD4 and CD8 cells, which increase the susceptibility to bacterial and fungal infections. One such opportunistic fungal infection is mucormycosis. Initially, it was debated whether a person taking immunosuppressants, such as corticosteroids, and monoclonal antibodies will be at higher risk for COVID-19 or whether the immunosuppresive state would cause a more severe COVID-19 disease. However, immunosuppressants are currently continued unless the patients are at greater risk of severe COVID-19 infection or are on high-dose corticosteroids therapy. As understood so far, COVID-19 infection may induce significant and persistent lymphopenia, which in turn increases the risk of opportunistic infections. It is also noted that 85% of the COVID-19 patients’ laboratory findings showed lymphopenia. This means that patients with severe COVID-19 have markedly lower absolute number of T lymphocytes, CD4+T and CD8+ T cells and, since the lymphocytes play a major role in maintaining the immune homeostasis, the patients with COVID-19 are highly susceptible to fungal co-infections. This report is intended to raise awareness of the importance of early detection and treatment of mucormycosis and other fungal diseases, such as candidiasis, SARS-CoV-2-associated pulmonary aspergillosis, pneumocystis pneumonia and cryptococcal disease, in COVID-19 patients, to reduce the risk of mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Candida auris Outbreak in a COVID-19 Specialty Care Unit — Florida, July–August 2020
Prestel, C., Anderson, E., Forsberg, K., Lyman, M., de Perio, M. A., Kuhar, D., Edwards, K., Rivera, M., Shugart, A., Walters, M., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7002e3 · Cited by 237
Cited by
Synergistic Effects Between Metal Nanoparticles and Commercial Antimicrobial Agents: A Review
Ribeiro, A. I., Dias, A. M., & Zille, A. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c03891 · Cited by 276
Antifungal activity of the repurposed drug disulfiram against Cryptococcus neoformans
Peng, M., Zhang, C., Duan, Y.-Y., Liu, H.-B., Peng, X.-Y., Wei, Q., Chen, Q.-Y., Sang, H., & Kong, Q.-T. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1268649 · Cited by 9
Metadata
- Authors
- Division of Clinical and Translational Research, L. H. S., Bhatt, K., Agolli, A., Division of Clinical and Translational Research, L. H. S., H. Patel, M., Division of Clinical and Translational Research, L. H. S., Garimella, R., Division of Clinical and Translational Research, L. H. S., Devi, M., Pakistan Ziauddin Medical College, K., Garcia, E., Larkin Community Hospital, H., Amin, H., Larkin Community Hospital, H., Domingue, C., Larkin Community Hospital, H., Del Castillo, R. G., Larkin Community Hospital, H., Sanchez-Gonzalez, M., & Division of Clinical and Translational Research, L. H. S.
- Venue
- Discoveries
- Publisher
- Applied Systems, srl
- Published
- 2021-03-31
- Volume
- 9
- Issue
- 1
- Pages
- e126
- ISSN
- 2359-7232 (ISSN-L)
- OpenAlex
- W3158760899
- Cited by
- 195
- References
- 1
- FWCI
- 12.44
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections. https://app.cochat.ai/papers/10.15190/d.2021.5
- The paper
- Division of Clinical and Translational Research, L. H. S., Bhatt, K., Agolli, A., Division of Clinical and Translational Research, L. H. S., H. Patel, M., Division of Clinical and Translational Research, L. H. S., Garimella, R., Division of Clinical and Translational Research, L. H. S., Devi, M., Pakistan Ziauddin Medical College, K., Garcia, E., Larkin Community Hospital, H., Amin, H., Larkin Community Hospital, H., Domingue, C., Larkin Community Hospital, H., Del Castillo, R. G., Larkin Community Hospital, H., Sanchez-Gonzalez, M., & Division of Clinical and Translational Research, L. H. S. (2021). High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections. Discoveries. https://doi.org/10.15190/d.2021.5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.